Connection

JASON KIMATA to Humans

This is a "connection" page, showing publications JASON KIMATA has written about Humans.
Connection Strength

0.352
  1. Variable antiviral activity of islatravir against M184I/V mutant HIV-1 selected during antiretroviral therapy. J Antimicrob Chemother. 2024 02 01; 79(2):370-374.
    View in: PubMed
    Score: 0.023
  2. Engineered CD4 T cells expressing a membrane anchored viral inhibitor restrict HIV-1 through cis and trans mechanisms. Front Immunol. 2023; 14:1167965.
    View in: PubMed
    Score: 0.023
  3. Glycosyl-Phosphatidylinositol-Anchored Anti-HIV Env Single-Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity. J Virol. 2018 04 01; 92(7).
    View in: PubMed
    Score: 0.015
  4. Challenges and strategies for the eradication of the HIV reservoir. Curr Opin Immunol. 2016 10; 42:65-70.
    View in: PubMed
    Score: 0.014
  5. Subversion of Cell Cycle Regulatory Mechanisms by HIV. Cell Host Microbe. 2015 Jun 10; 17(6):736-40.
    View in: PubMed
    Score: 0.013
  6. Stepping toward a macaque model of HIV-1 induced AIDS. Viruses. 2014 Sep 25; 6(9):3643-51.
    View in: PubMed
    Score: 0.012
  7. A variant macaque-tropic human immunodeficiency virus type 1 is resistant to alpha interferon-induced restriction in pig-tailed macaque CD4+ T cells. J Virol. 2013 Jun; 87(12):6678-92.
    View in: PubMed
    Score: 0.011
  8. Absence of XMRV in peripheral blood mononuclear cells of ARV-treatment na?ve HIV-1 infected and HIV-1/HCV coinfected individuals and blood donors. PLoS One. 2012; 7(2):e31398.
    View in: PubMed
    Score: 0.010
  9. Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1. J Virol. 2011 Apr; 85(8):3767-79.
    View in: PubMed
    Score: 0.009
  10. Detection of xenotropic murine leukemia virus-related virus in normal and tumor tissue of patients from the southern United States with prostate cancer is dependent on specific polymerase chain reaction conditions. J Infect Dis. 2010 Nov 15; 202(10):1470-7.
    View in: PubMed
    Score: 0.009
  11. Dendritic cell-mediated HIV-1 infection of T cells demonstrates a direct relationship to plasma viral RNA levels. J Acquir Immune Defic Syndr. 2010 Jun; 54(2):115-21.
    View in: PubMed
    Score: 0.009
  12. ICAM-3 influences human immunodeficiency virus type 1 replication in CD4(+) T cells independent of DC-SIGN-mediated transmission. Virology. 2007 Aug 01; 364(2):383-94.
    View in: PubMed
    Score: 0.007
  13. Elimination of Human Immunodeficiency Virus Reservoirs Harboring Intact Proviruses. J Infect Dis. 2026 Feb 18; 233(2):267-277.
    View in: PubMed
    Score: 0.007
  14. HIV-1 fitness and disease progression: insights from the SIV-macaque model. Curr HIV Res. 2006 Jan; 4(1):65-77.
    View in: PubMed
    Score: 0.007
  15. Localized inflammasome inhibition mitigates foreign body response to subcutaneous long-acting antiretroviral therapy for HIV. J Control Release. 2026 Feb 10; 390:114559.
    View in: PubMed
    Score: 0.007
  16. Optimization of Cellular Transduction by the HIV-Based Pseudovirus Platform with Pan-Coronavirus Spike Proteins. Viruses. 2024 09 20; 16(9).
    View in: PubMed
    Score: 0.006
  17. Domains of macaque DC-SIGN essential for capture and transfer of simian immunodeficiency virus. Virology. 2004 Jun 20; 324(1):194-203.
    View in: PubMed
    Score: 0.006
  18. Pro-inflammatory feedback loops define immune responses to pathogenic Lentivirus infection. Genome Med. 2024 02 05; 16(1):24.
    View in: PubMed
    Score: 0.006
  19. Pseudoviruses, a safer toolbox for vaccine development against enveloped viruses. Expert Rev Vaccines. 2024 Jan-Dec; 23(1):174-185.
    View in: PubMed
    Score: 0.006
  20. Antiviral potency of long-acting islatravir subdermal implant in SHIV-infected macaques. J Control Release. 2024 02; 366:18-27.
    View in: PubMed
    Score: 0.006
  21. A rapid, high-throughput, viral infectivity assay using automated brightfield microscopy with machine learning. SLAS Technol. 2023 Oct; 28(5):324-333.
    View in: PubMed
    Score: 0.006
  22. From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global access. Expert Rev Vaccines. 2023 Jan-Dec; 22(1):495-500.
    View in: PubMed
    Score: 0.005
  23. Capture and transfer of simian immunodeficiency virus by macaque dendritic cells is enhanced by DC-SIGN. J Virol. 2002 Dec; 76(23):11827-36.
    View in: PubMed
    Score: 0.005
  24. HIV-1 subtype F integrase polymorphisms external to the catalytic core domain contribute to severe loss of replication capacity in context of the integrase inhibitor resistance mutation Q148H. J Antimicrob Chemother. 2022 09 30; 77(10):2793-2802.
    View in: PubMed
    Score: 0.005
  25. Highly pathogenic simian immunodeficiency virus mne variants that emerge during the course of infection evolve enhanced infectivity and the ability to downregulate CD4 but not class I major histocompatibility complex antigens. J Virol. 2002 Jul; 76(13):6425-34.
    View in: PubMed
    Score: 0.005
  26. Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern. Vaccine. 2022 06 09; 40(26):3655-3663.
    View in: PubMed
    Score: 0.005
  27. Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate. Protein Expr Purif. 2022 02; 190:106003.
    View in: PubMed
    Score: 0.005
  28. Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2. Front Immunol. 2021; 12:693462.
    View in: PubMed
    Score: 0.005
  29. SARS-CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice. Hum Vaccin Immunother. 2021 08 03; 17(8):2356-2366.
    View in: PubMed
    Score: 0.005
  30. IP-10 and CXCR3 signaling inhibit Zika virus replication in human prostate cells. PLoS One. 2020; 15(12):e0244587.
    View in: PubMed
    Score: 0.005
  31. Reply. J Allergy Clin Immunol. 2020 12; 146(6):1455-1456.
    View in: PubMed
    Score: 0.005
  32. Clearance of HIV infection by selective elimination of host cells capable of producing HIV. Nat Commun. 2020 08 13; 11(1):4051.
    View in: PubMed
    Score: 0.005
  33. Timing of Antiretroviral Therapy Initiation Determines Rectal Natural Killer Cell Populations. AIDS Res Hum Retroviruses. 2020 04; 36(4):314-323.
    View in: PubMed
    Score: 0.004
  34. PACS1 is an HIV-1 cofactor that functions in Rev-mediated nuclear export of viral RNA. Virology. 2020 01 15; 540:88-96.
    View in: PubMed
    Score: 0.004
  35. Efficient pre-catalytic conformational change of reverse transcriptases from SAMHD1 non-counteracting primate lentiviruses during dNTP incorporation. Virology. 2019 11; 537:36-44.
    View in: PubMed
    Score: 0.004
  36. Coreceptor specificity of temporal variants of simian immunodeficiency virus Mne. J Virol. 1999 Feb; 73(2):1655-60.
    View in: PubMed
    Score: 0.004
  37. Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection. PLoS Pathog. 2018 02; 14(2):e1006888.
    View in: PubMed
    Score: 0.004
  38. Replication of Zika Virus in Human Prostate Cells: A Potential Source of Sexually Transmitted Virus. J Infect Dis. 2018 01 30; 217(4):538-547.
    View in: PubMed
    Score: 0.004
  39. A lymph node-derived cytopathic simian immunodeficiency virus Mne variant replicates in nonstimulated peripheral blood mononuclear cells. J Virol. 1998 Jan; 72(1):245-56.
    View in: PubMed
    Score: 0.004
  40. The cytopathicity of a simian immunodeficiency virus Mne variant is determined by mutations in Gag and Env. J Virol. 1997 Oct; 71(10):7629-39.
    View in: PubMed
    Score: 0.004
  41. Plasma Levels of Complement Factor I and C4b Peptides Are Associated with HIV Suppression. ACS Infect Dis. 2017 12 08; 3(12):880-885.
    View in: PubMed
    Score: 0.004
  42. Efficient Transduction of Human and Rhesus Macaque Primary T Cells by a Modified Human Immunodeficiency Virus Type 1-Based Lentiviral Vector. Hum Gene Ther. 2017 03; 28(3):271-285.
    View in: PubMed
    Score: 0.004
  43. The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1. J Virol. 2016 Dec 01; 90(23):10642-10659.
    View in: PubMed
    Score: 0.004
  44. Glycosyl Phosphatidylinositol-Anchored C34 Peptide Derived From Human Immunodeficiency Virus Type 1 Gp41 Is a Potent Entry Inhibitor. J Neuroimmune Pharmacol. 2016 09; 11(3):601-10.
    View in: PubMed
    Score: 0.003
  45. The viral restriction factor tetherin prevents leucine-rich pentatricopeptide repeat-containing protein (LRPPRC) from association with beclin 1 and B-cell CLL/lymphoma 2 (Bcl-2) and enhances autophagy and mitophagy. J Biol Chem. 2015 Mar 13; 290(11):7269-79.
    View in: PubMed
    Score: 0.003
  46. CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection. PLoS One. 2014; 9(12):e115987.
    View in: PubMed
    Score: 0.003
  47. Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. Virology. 1994 Nov 01; 204(2):656-64.
    View in: PubMed
    Score: 0.003
  48. CD3-dependent lymphocyte activation by human T cell leukaemia virus type I-producing T cells. J Gen Virol. 1994 Sep; 75 ( Pt 9):2433-7.
    View in: PubMed
    Score: 0.003
  49. HIV replication in conjunction with granzyme B production by CCR5+ memory CD4 T cells: Implications for bystander cell and tissue pathologies. Virology. 2014 Aug; 462-463:175-88.
    View in: PubMed
    Score: 0.003
  50. The mitogenic activity of human T-cell leukemia virus type I is T-cell associated and requires the CD2/LFA-3 activation pathway. J Virol. 1993 Jun; 67(6):3134-41.
    View in: PubMed
    Score: 0.003
  51. Vpx is critical for SIVmne infection of pigtail macaques. Retrovirology. 2012 Apr 24; 9:32.
    View in: PubMed
    Score: 0.003
  52. Temporal regulation of viral and cellular gene expression during human T-lymphotropic virus type I-mediated lymphocyte immortalization. J Virol. 1991 Aug; 65(8):4398-407.
    View in: PubMed
    Score: 0.002
  53. Potent and broad anti-HIV-1 activity exhibited by a glycosyl-phosphatidylinositol-anchored peptide derived from the CDR H3 of broadly neutralizing antibody PG16. J Virol. 2011 Sep; 85(17):8467-76.
    View in: PubMed
    Score: 0.002
  54. GPI-anchored single chain Fv--an effective way to capture transiently-exposed neutralization epitopes on HIV-1 envelope spike. Retrovirology. 2010 Oct 06; 7:79.
    View in: PubMed
    Score: 0.002
  55. A seroepidemiologic survey of human T-cell lymphotropic virus type I in two Hawaiian hematologic-oncologic practices. West J Med. 1989 Mar; 150(3):300-2.
    View in: PubMed
    Score: 0.002
  56. Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy. J Virol. 2007 Nov; 81(22):12145-55.
    View in: PubMed
    Score: 0.002
  57. A nonneutralizing anti-HIV Type 1 antibody turns into a broad neutralizing antibody when expressed on the surface of HIV type 1-susceptible cells. II. Inhibition of HIV type 1 captured and transferred by DC-SIGN. AIDS Res Hum Retroviruses. 2006 Sep; 22(9):874-83.
    View in: PubMed
    Score: 0.002
  58. Integration of human immunodeficiency virus type 1 in untreated infection occurs preferentially within genes. J Virol. 2006 Aug; 80(15):7765-8.
    View in: PubMed
    Score: 0.002
  59. Functional and antigenic characterization of human, rhesus macaque, pigtailed macaque, and murine DC-SIGN. J Virol. 2001 Nov; 75(21):10281-9.
    View in: PubMed
    Score: 0.001
  60. Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR-5 coreceptor recognition. J Virol. 1998 Jan; 72(1):209-17.
    View in: PubMed
    Score: 0.001
  61. Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population. Virology. 1995 Mar 10; 207(2):528-42.
    View in: PubMed
    Score: 0.001
  62. Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A. 1995 Feb 14; 92(4):1057-61.
    View in: PubMed
    Score: 0.001
  63. Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid. Proc Natl Acad Sci U S A. 1989 Nov; 86(22):8655-9.
    View in: PubMed
    Score: 0.001
  64. HTLV-1 seroconversion in a 56-year-old Japanese woman undergoing chemotherapy for acute nonlymphocytic leukemia. Hawaii Med J. 1988 Jun; 47(6):269-70, 273.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.